Parkinson's disease is the second most common neurodegenerative disease and its
prevalence has been projected to double over the next 30 years. An accurate diagnosis of …

Introduction Parkinson's disease (PD) is a chronic neurodegenerative disorder that presents
with motor and non‐motor manifestations. Amongst the non‐motor features, various forms of …

Longitudinal, remote monitoring of motor symptoms in Parkinson's disease (PD) could
enable more precise treatment decisions. We developed the Motor fluctuations Monitor for …

In Parkinson's disease and other synucleinopathies, the elevation of α-synuclein
phosphorylated at Serine129 (pS129) is a widely cited marker of pathology. However, the …

Long-term effects of continuous subcutaneous apomorphine infusion (CSAI) on health-
related quality of life (HRQoL) and predictors of CSAI discontinuation are poorly known …

Neuroplasticity is the capacity of neural networks in the brain to alter through development
and rearrangement. It can be classified as structural and functional plasticity. The …

Introduction Non-motor symptoms (NMS) affect patients with Parkinson's disease (PD) from
the prodromal to the advanced stages. NMS phenotypes greatly vary and have a huge …

Background CD4+ T‐cell dysregulation occurs in Parkinson's disease (PD); however, it is
unknown whether it contributes to PD development. The objective of this study was to …

Background: Sexual dysfunctions (SD) are common but underreported in Parkinson's
disease (PD) and have negative impacts on the quality of life (QoL) and partnership …

Objective: Cognitive impairment and depression are among the most prevalent and most
disabling non-motor symptoms in Parkinson's disease (PD). The genetic factors that are …